Amrize stock: JPMorgan cuts price target to $46
Published on 11/20/2026 at 17:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst view turns more cautious
- JPMorgan kept its Neutral rating on Amrize.
- The decision adds to mixed analyst views on the building-materials company.
- Investors are focused on volume, costs and the outlook for 2027.
JPMorgan lowered its price target for Amrize on Thursday, November 19, while keeping a Neutral rating on the shares. MarketBeat said the bank reduced its target from 48 US dollars to 46 US dollars.
Mixed signals for 2027
The move leaves JPMorgan's rating unchanged but points to a more restrained valuation view. MarketBeat reported that analysts remain divided, with recent target changes ranging from more constructive views to downgrades tied to roofing margins and demand.
Amrize supplies cement, aggregates, ready-mix concrete, asphalt and roofing products in the United States and Canada. The key operating questions for investors remain construction volumes, input costs and the pace of improvement in the Building Envelope business.
What investors watch next
The latest analyst action shifts attention toward execution in 2027 rather than a new company announcement. A more durable recovery in pricing and margins would support the investment case, while weaker residential demand or persistent cost inflation would keep earnings expectations under pressure.
Amrize Ltd at a glance
- Company: Amrize Ltd
- ISIN: CH1430134226
- Ticker: AMRZ
- Primary listing: New York Stock Exchange
Current market developments can be followed in Current market reports.
